tarzapine 45 mg tabletti, kalvopäällysteinen
apotex nederland bv - mirtazapinum - tabletti, kalvopäällysteinen - 45 mg - mirtatsapiini
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogreelibesilata - peripheral vascular diseases; stroke; myocardial infarction - antitromboottiset aineet - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segmentin nousua akuutti sydäninfarkti, yhdessä asa lääketieteellisesti hoitoa saaneilla potilailla oikeutettu liuotushoito. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. lisätietoja, katso kohta 5.
lutrate 22.5 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten
gp-pharm s.a. gp-pharm s.a. - leuprorelini acetas - injektiokuiva-aine ja liuotin, depotsuspensiota varten - 22.5 mg - leuproreliini
lutrate 3.75 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten
gp-pharm s.a. gp-pharm s.a. - leuprorelini acetas - injektiokuiva-aine ja liuotin, depotsuspensiota varten - 3.75 mg - leuproreliini
terracort voide
pfizer oy - hydrocortisone, oxytetracycline hydrochloride - voide - hydrokortisoni ja antibiootit
terra-cortril-p korva-/silmätipat, suspensio
pfizer oy - hydrocortisone acetate, oxytetracycline hydrochloride, polymyxin b sulfate - korva-/silmätipat, suspensio - hydrokortisoni ja mikrobilääkkeet
terra-cortril-p korva-/silmävoide
pfizer oy - hydrocortisone acetate, oxytetracycline hydrochloride, polymyxin b sulfate - korva-/silmävoide - hydrokortisoni ja mikrobilääkkeet
aqua sterilisata braun infuusioneste, liuos
b. braun melsungen ag - water for injection - infuusioneste, liuos - liuottimet ja laimentimet
aqua sterilisata braun liuotin parenteraaliseen käyttöön
b. braun melsungen ag - water for injection - liuotin parenteraaliseen käyttöön - liuottimet ja laimentimet
natriumklorid braun 9 mg/ml injektioneste, liuos
b. braun melsungen ag - sodium chloride - injektioneste, liuos - 9 mg/ml - liuottimet ja laimentimet